Gastrointestinal Cancer | Topics

FDA Grants Priority Review to Infigratinib to Treat Cholangiocarcinoma
December 01, 2020

The agent’s new drug application will be reviewed under the FDA’s Real Time Oncology Review pilot program and under Project Orbis.

Rates of Hepatocellular Carcinoma Cases Slow in Urban Areas, Increase in Rural Areas Since 2009
November 30, 2020

A recent study found that rural non-Hispanic whites and blacks have experienced increased HCC case incidence rates, while urban areas have seen the rate decline since 2009.

UDCA May Be Associated with Reduction of Biliary Tract Cancer, Need for Liver Transplantation
November 24, 2020

Data from a Japanese cohort of patients with primary sclerosing cholangitis suggested ursodeoxycholic acid (UDCA) was significantly associated with reduced mortality or need for liver transplantation and was also likely to be associated with a reduction of biliary tract cancer.